Zepp Health Corporation, a biometric and activity data-driven company, develops, manufactures, and sells smart wearable technological devices in the People's Republic of China. It operates through two segments, Xiaomi Wearable Products, and Self-Branded Products and Others. The company offers smart bands, watches, and scales; and a range of accessories, including bands, watch straps, earphones, sportswear, home gym, treadmill, etc. under the Xiaomi and Amazfit brands. It provides charts and graphs to display analysis of the activity and biometric data collected from users through its Mi Fit and Amazfit mobile apps. Zepp Health Corporation has strategic collaborations with Timex Group to develop smart watches; and AliveCor, Inc. to deliver a medical functionality to wearable devices. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.
IPO Year:
Exchange: NYSE
Website: https://www.huami.com
MILPITAS, Calif., and LAS VEGAS, Jan. 6, 2025 /PRNewswire/ -- Zepp Clarity, the smart hearing solutions brand owned by Zepp Health (NYSE:ZEPP), a health technology company, today unveiled its innovative "Try Before You Buy" program at CES 2025. This initiative addresses a critical gap in hearing aid adoption by encouraging the older population to explore hearing solutions in a low-pressure, hands-on environment. Despite the widespread prevalence of disabling age-related hearing loss, industry surveys and epidemiological studies have consistently documented that only 15% to 30%
MILPITAS, Calif., Jan. 6, 2025 /PRNewswire/ -- Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE:ZEPP), a health technology company, today announced the launch of its latest lifestyle smartwatch: the Amazfit Active 2, a wearable that bridges elegance and functionality. Debuting at CES 2025 and featured at Pepcom and ShowStoppers media events, the Amazfit Active 2 is a lifestyle statement for fashion conscious and health-oriented consumers who want to monitor their fitness without compromising on aesthetics. Stylish Design Meets Competitive Advantages Along with a body crafted from stainless steel, the Amazfit Active 2 boasts a round 1.32-inch high-definition AMOLED
CES -- Zepp Health Corporation (NYSE:ZEPP), a global leader in health technology and smart wearables, is thrilled to announce its participation in the CES Pepcom and ShowStoppers media events. These exclusive platforms will unveil Zepp Health's latest smart wearables and health technology advancements, designed to empower individuals to lead healthier, more balanced lives. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250106641263/en/(Graphic: Business Wire) Zepp Health is on a mission to empower people with intelligent healthcare tools that help them take charge of their well-being. Its innovative products integrate fitness, n
MILPITAS, Calif., Nov. 18, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of US$42.5 million; a basic and diluted net loss per share of US$0.05; and a basic and diluted net loss per ADS of US$0.82 for the third quarter ended September 30, 2024; adjusted basic and diluted net loss per share of US$0.05; and adjusted basic and diluted net loss per ADS of US$0.78. Each ADS represents sixteen Class A ordinary shares. Mr. Wang 'Wayne' Huang, Chairman and CEO of Zepp, commented, "I'm pleased to report that this quarter our Amazfit branded sales had a 10% quarter-over-quarter increase, the highest sequential growth we've achieved this year
Earnings Call Scheduled for 8:30 p.m. ET on November 18, 2024 MILPITAS, Calif., Nov. 5, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that it will report its third quarter 2024 unaudited financial results after the market close on Monday, November 18, 2024. Management will hold a conference call at 8:30 p.m. Eastern Time on Monday, November 18, 2024. Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Toll Free): 800-905-945 Hong Kong: +852-3018-4992 Participants should
MILPITAS, Calif., Oct. 31, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced the launch of the enhanced Zepp App 9. This latest app version is designed to deliver a more personalized health, wellness, and fitness experience, empowering Amazfit users worldwide to understand their health trends and make informed lifestyle decisions. Zepp App 9 is available on iOS and Android platforms and compatible with all Amazfit devices. Key Enhancements in Zepp App 9: A New, Improved Free Zepp App Core Experience Enhanced User Interface: The new, streamlined interface features color-coded statistics, daily s
MILPITAS, Calif., Oct. 2, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that it has received a letter from the New York Stock Exchange ("NYSE") dated October 2, 2024 (the "October Letter"), notifying the Company that it has regained compliance with the NYSE's continued listing criterion of a minimum share price as set forth in Section 802.01C of the NYSE Listed Company Manual (the "NYSE Minimum Price Continued Listing Criterion"). As previously announced, the Company received a letter from the NYSE dated April 30, 2024, notifying the Company that it was below compliance sta
Zepp Health's Amazfit smartwatches and fitness wearables continue to unlock potential for endurance athletes with unparalleled performance benefits Amazfit, a leading global smart wearable brand by Zepp Health (NYSE:ZEPP), today is excited to announce that HYROX champions Meg Jacoby and Hunter McIntyre have been added to Amazfit's growing roster of international athletes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240912022365/en/Zepp Health's Amazfit smartwatches and fitness wearables continue to unlock potential for endurance athletes with unparalleled performance benefits (Photo: Business Wire) This follows the recent ann
MILPITAS, Calif., Sept. 6, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that it will change the ratio of its American depositary shares ("ADSs") to its Class A ordinary shares (the "ADS Ratio") from one (1) ADS representing four (4) Class A ordinary shares to one (1) ADS representing sixteen (16) Class A ordinary shares. For the Company's ADS holders, the change in the ADS Ratio will have the same effect as a one-for-four reverse ADS split. A post-effective amendment to the ADS Registration Statement on Form F-6 will be filed with the SEC to reflect the change in the ADS R
-Powered by Zepp Health, the T-Rex 3 Combines Durability with Advanced Privacy Features for Everyday Adventurers BERLIN, Sept. 6, 2024 /PRNewswire/ -- Amazfit, a leading global smart wearable brand by Zepp Health (NYSE:ZEPP), today unveiled the Amazfit T-Rex 3 smartwatch at the IFA Berlin trade event. Designed for the modern explorer, the Amazfit T-Rex 3 combines military-grade durability, cutting-edge outdoor navigation features, and unparalleled battery life, making it the perfect companion for those who seek adventure in their everyday lives. Key Product Differentiators Design: The AMOLED display is 16% larger and 100% brighter than the previous generation, while the body is upgraded wit
SC 13G/A - Zepp Health Corp (0001720446) (Subject)
SC 13G/A - Zepp Health Corp (0001720446) (Subject)
SC 13G/A - Zepp Health Corp (0001720446) (Subject)
SC 13G/A - Zepp Health Corp (0001720446) (Subject)
SC 13G/A - Zepp Health Corp (0001720446) (Subject)
SC 13G/A - Zepp Health Corp (0001720446) (Subject)
SC 13G/A - Zepp Health Corp (0001720446) (Subject)
SC 13G/A - Zepp Health Corp (0001720446) (Subject)
SC 13G/A - Zepp Health Corp (0001720446) (Subject)
SC 13G/A - Zepp Health Corp (0001720446) (Subject)
MILPITAS, Calif., Nov. 18, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of US$42.5 million; a basic and diluted net loss per share of US$0.05; and a basic and diluted net loss per ADS of US$0.82 for the third quarter ended September 30, 2024; adjusted basic and diluted net loss per share of US$0.05; and adjusted basic and diluted net loss per ADS of US$0.78. Each ADS represents sixteen Class A ordinary shares. Mr. Wang 'Wayne' Huang, Chairman and CEO of Zepp, commented, "I'm pleased to report that this quarter our Amazfit branded sales had a 10% quarter-over-quarter increase, the highest sequential growth we've achieved this year
Earnings Call Scheduled for 8:30 p.m. ET on November 18, 2024 MILPITAS, Calif., Nov. 5, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that it will report its third quarter 2024 unaudited financial results after the market close on Monday, November 18, 2024. Management will hold a conference call at 8:30 p.m. Eastern Time on Monday, November 18, 2024. Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Toll Free): 800-905-945 Hong Kong: +852-3018-4992 Participants should
MILPITAS, Calif., Aug. 21, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of US$40.6 million; a basic and diluted net loss per share of US$0.04; and a basic and diluted net loss per ADS of US$0.17 for the second quarter ended June 30, 2024; adjusted basic and diluted net loss per share of US$0.04; and adjusted basic and diluted net loss per ADS of US$0.15. Each ADS represents four Class A ordinary shares. Starting from the second quarter of 2024, the Company changed its reporting currency from Renminbi ("RMB") to U.S.dollar ("US$"), to reduce the impact of increased volatility of the RMB to US$ exchange rate on the Company's report
Earnings Call Scheduled for 9:30 p.m. ET on August 21, 2024 MILPITAS, Calif., Aug. 8, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its second quarter 2024 unaudited financial results after the market close on Wednesday, August 21, 2024. Management will hold a conference call at 9:30 p.m. Eastern Time on Wednesday, August 21, 2024 (9:30 a.m. Beijing Time on August 22, 2024). Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong
MILPITAS, Calif., May 20, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of US$39.8 million; a basic and diluted net loss per share of US$0.06; and a basic and diluted net loss per ADS of US$0.23 for the first quarter ended March 31, 2024; adjusted basic and diluted net loss per share of US$0.05; and adjusted basic and diluted net loss per ADS of US$0.19. Each ADS represents four Class A ordinary shares. Mr. Wang 'Wayne' Huang, Chairman and CEO of Zepp, commented, "In the first quarter of 2024, our revenue came broadly in line with our guidance. Our gross margin performance reached a record high, and our self-branded product sales
Earnings Call Scheduled for 7:00 p.m. ET on May 20, 2024 MILPITAS, Calif., May 8, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its first quarter 2024 unaudited financial results after the market close on Monday, May 20, 2024. Management will hold a conference call at 7:00 p.m. Eastern Time on Monday, May 20, 2024 (7:00 a.m. Beijing Time on May 21, 2024). Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Toll Free): 80
MILPITAS, Calif., March 18, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of US$84.5 million (RMB0.6 billion); a basic and diluted net loss per share of US$0.005 (RMB0.03); and a basic and diluted net loss per ADS of US$0.02 (RMB0.14) for the fourth quarter ended December 31, 2023; adjusted basic and diluted net income per share of US$0.002 (RMB0.01); and adjusted basic and diluted net income per ADS of US$0.01 (RMB0.06). Each ADS represents four Class A ordinary shares. Mr. Wang 'Wayne' Huang, Chairman and CEO of Zepp, commented, "In the fourth quarter, we continued to make substantial progress in our strategic transformation, a
Earnings Call Scheduled for 7:00 p.m. ET on March 18, 2024 AMSTERDAM, March 7, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its fourth quarter and full year 2023 unaudited financial results after the market close on Monday, March 18, 2024. Management will hold a conference call at 7:00 p.m. Eastern Time on Monday, March 18, 2024 (7:00 a.m. Beijing Time on March 19, 2024). Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Ko
AMSTERDAM, Nov. 20, 2023 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of RMB0.6 billion (US$82.5 million); a basic and diluted net income per share of RMB0.01 (US$0.002); and a basic and diluted net income per ADS of RMB0.05 (US$0.01) for the third quarter ended September 30, 2023. Each ADS represents four Class A ordinary shares. Mr. Wayne Wang Huang, Chairman and CEO of Zepp, commented, "In the third quarter, we achieved a business turnaround, returning to profitability after six loss-making quarters. Despite a year-over-year revenue decline, our high-margin self-branded products' contribution to our top line grew to approximately 8
AMSTERDAM, Aug. 21, 2023 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of RMB0.65 billion (US$89.4 million); a basic and diluted net loss per share of RMB0.29 (US$0.04); and a basic and diluted net loss per ADS of RMB1.15 (US$0.16) for the second quarter ended June 30, 2023. Each ADS represents four Class A ordinary shares. "In the second quarter of 2023, we were delighted to witness our strategic transformation from a company heavily reliant on a single customer for revenue to becoming a self-reliant, global smart wearable and healthcare solution provider yielding early success, as our self-branded products contributed 68% of our top l
6-K - Zepp Health Corp (0001720446) (Filer)
6-K - Zepp Health Corp (0001720446) (Filer)
F-6 POS - Zepp Health Corp (0001720446) (Subject)
6-K - Zepp Health Corp (0001720446) (Filer)
6-K - Zepp Health Corp (0001720446) (Filer)
6-K - Zepp Health Corp (0001720446) (Filer)
20-F/A - Zepp Health Corp (0001720446) (Filer)
6-K - Zepp Health Corp (0001720446) (Filer)
20-F - Zepp Health Corp (0001720446) (Filer)
6-K - Zepp Health Corp (0001720446) (Filer)